Multiple myeloma and Diffuse alveolar damage

Summary:

Diffuse alveolar damage is found among people with Multiple myeloma, especially for people who are male, 60+ old.

The study analyzes which people have Diffuse alveolar damage with Multiple myeloma. It is created by eHealthMe based on reports of 23 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

What is Diffuse alveolar damage?

Diffuse alveolar damage (common manifestation of drug-induced lung injury) is found to be associated with 145 drugs and 361 conditions by eHealthMe. Check the latest studies of Diffuse alveolar damage.



On Aug, 01, 2026

23 people who have Multiple Myeloma and Diffuse Alveolar Damage are studied.

Would you have Diffuse alveolar damage when you have Multiple myeloma?

Gender of people who have Multiple Myeloma and experienced Diffuse Alveolar Damage *:

  • female: 47.83 %
  • male: 52.17 %

Age of people who have Multiple Myeloma and experienced Diffuse Alveolar Damage *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.18 %
  • 50-59: 18.18 %
  • 60+: 63.64 %

Common co-existing conditions for these people *:

  1. Infection: 3 people, 13.04%
  2. High Blood Pressure: 1 person, 4.35%
  3. Breast Cancer Metastatic: 1 person, 4.35%

Common drugs taken by these people *:

  1. Velcade: 14 people, 60.87%
  2. Acyclovir: 7 people, 30.43%
  3. Itraconazole: 6 people, 26.09%
  4. Amlodipine Besylate: 5 people, 21.74%
  5. Diovan: 5 people, 21.74%
  6. Revlimid: 4 people, 17.39%
  7. Humalog: 4 people, 17.39%
  8. Decadron: 4 people, 17.39%
  9. Mycostatin: 3 people, 13.04%
  10. Cotrim: 3 people, 13.04%

Common symptoms for these people *:

  1. Pneumonia: 14 people, 60.87%
  2. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 12 people, 52.17%
  3. Pleural Effusion (water on the lungs): 9 people, 39.13%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 9 people, 39.13%
  5. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 6 people, 26.09%
  6. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 6 people, 26.09%
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 21.74%
  8. Cerebral Aspergillosis (pus collection with swelling in brain): 5 people, 21.74%
  9. Pseudomonal Bacteraemia (p. aeruginosa cause of bacterial infections of the blood): 5 people, 21.74%
  10. Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 21.74%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Diffuse alveolar damage?

- Check whether Diffuse alveolar damage is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Diffuse alveolar damage:

All the conditions that are associated with Diffuse alveolar damage:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Diffuse alveolar damage and Multiple myeloma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: